OxyMem
About
Our mission is to make OxyMem MABR the mainstream choice for Biological Aeration for Industrial and Municipal Wastewater Plants.
Conventional wastewater treatment consumes 2-3% of a nation’s electricity production. This is due a 100 years reliance on bubble diffusion for conventional treatment plants which will typically suffer energy losses of 65-70% in the process because of the oxygen transfer limitations in the bubble aeration process.
The Membrane Aerated Biofilm Reactor (MABR) does not have any such 
limitations. OxyMem MABR does not rely on bubbles to deliver oxygen which makes it 75% more energy efficient.
We are committed to innovation and continuous improvement
OxyMem is recognised as developing the world’s first commercially available Membrane Aerated Biofilm Reactor (MABR). A leading edge technology for the wastewater treatment market.
We are committed to maintaining the level of technical excellence that has been necessary to deliver the first commercial MABR. We will continue to work with our research partners and our customers to advance innovation around this smart aeration solution so as to remain the recognised pioneer of Membrane Aerated Biofilm Reactor.
Information
- Website: http://www.oxymem.com/
- Phone: +353 906 465727
- Location: Ireland
Taxonomy
- Technology
- Membrane Technology
- Membrane Filtration